Reply to Angeletti et al-Efficacy of combined rituximab and daratumumab treatment in posttransplant recurrent focal segmental glomerulosclerosis.

Published in: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons (2024)